All locations are open. Call your doctor today to schedule an in-person appointment or a doctor video visit.
Learn about our COVID-SAFE Care • Latest Visitor Policy and Service Updates • Donate and Lend Support


Todos los centros abiertos. Llame al médico hoy para una cita en persona o para una video visita médica.
Sepa qué es la Salud A SALVO DE COVID • Novedades de servicios y normas de visitas • Done y dé apoyo

Learn more

Fellow's Publications

Abstracts

2018

  1. Shah UA, Chung EY, Giricz O, Pradhan K, Kataoka K, Gordon-Mitchell S, Bhagat TD, Mai Y, Wei Y, Ishida E, Choudhary GS, Joseph A, Rice R, Gitego N, Parrish C, Bartenstein M, Goel S, Mantzaris I, Shastri A, Derman O, Binder A, Gritsman K, Kornblum N, Braunschweig I, Bhagat C, Hall J, Graber A, Ratner L, Wang Y, Ogawa S, Verma A, Ye BH, Janakiram M.North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood. 2018;132(14):1507-1518. doi:10.1182/blood-2018-01-824607.
  2. Mateo Mejia, Aditi Shastri, Adam Binder; Comparison of characteristics and outcomes of follicular lymphoma cohort between a cancer center and the SEER registry. J Clin Oncol 36, 2018 (suppl; abstr e19558).
  3. Audrey E. Kam, Mohammad Haroon Ghalib, Imran Chaudhary, Sridhar Mani, Sanjay Goel; Clinical benefit for minority patients (pts) with advanced refractory cancer versus non Hispanic whites (NHW) when enrolled on early phase (I) clinical trials. J Clin Oncol 36, 2018 (suppl; abstr e18634).
  4. Shirin Attarian, Elham Azimi-Nekoo, Justin Tang, Janaki Neela Sharma, Rafi Kabarriti, Adam Binder; Increased length of stay and cost of hospitalization in patients receiving inpatient radiation therapy. J Clin Oncol 36, 2018 (suppl; abstr e18936).
  5. Aditi Puri Singh, Elaine Shum, Haiying Cheng, Lakshmi Rajdev, Balazs Halmos; Impact and diagnostic gaps of multiplex genomic profiling (MGP) in an academic community-based cancer center. J Clin Oncol 36, 2018 (suppl; abstr e24154).
  6. Shirin Attarian, Aditi Puri Singh, Christopher Su, Missak Haigentz, Haiying Cheng, Vipul Pareek, Mindy Ginsberg, Xiaoling Guo, Balazs Halmos; Institutional cohort study of HIV-positive patients with lung cancer: Implications for screening? J Clin Oncol 36, 2018 (suppl; abstr e13582).
  7. Aditi Puri Singh, Qin-fang Deng, Qiyu Fang, Hui Sun, Shenduo Li, Haiying Cheng, Songwen Zhou; Circulating free DNA (cfDNA) for personalized treatment of lung cancer patients without cytopathologic diagnosis. J Clin Oncol 36, 2018 (suppl; abstr e21143).
  8. Jose Nahun Galeas, Stuart H. Packer, Susan Sakalian, Royston Browne, Adam Binder; Decreasing initiation of chemotherapy time in elective patients admitted to an inpatient hematology malignancy unit. J Clin Oncol 36, 2018 (suppl 30; abstr 120).
  9. Audrey E. Kam, Gopichand Pendurti, Umang H. Shah, Mohammad Haroon Ghalib, Imran Chaudhary, Sengottuvel Viswanathan, Ioannis Mantzaris, Sanjay Goel; Clinical outcome and prognosis of metastatic colorectal cancer (mCRC) patients (pts) on phase 1 trials: A single institution experience from 1999 to 2016. J Clin Oncol 36, 2018 (suppl 4S; abstr 828).
  10. Kevin Wong, Michael Shusterman, Sanjay Goel, Abdissa Negassa, Juan Lin, Janaki Neela Sharma, Benjamin Adam Gartrell; Racial diversity among histology of renal cell carcinoma at an urban medical center. J Clin Oncol 36, 2018 (suppl 6S; abstr 622).
  11. Gurbakhash Kaur, MD MA, BS, Mateo Mejia Saldarriaga, MD, Ana Acuna-Villaorduna, MD, Mohammad Kazemi, Sakshi Jasra, MD, Nishi Shah, MBBS, MPH, Ioannis Mantzaris, MD MS, Aditi Shastri, MD, Olga Derman, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Amit Verma, MD, Murali Janakiram, MD MS; Multiple Myeloma in Hispanics Is Associated with Better Survival Than Non-Hispanic African Americans and Whites: Analysis from a Large Single Center Minority Rich Cohort. Blood. 2018; 132Supplement 13601 doi: https://doi.org/10.1182/blood-2018-99-120282.
  12. Ana Acuna-Villaorduna, MD, Jesus D Gonzalez-Lugo, B. Hilda Ye, PhD, Urvi A Shah, MD, Gurbakhash Kaur, MDMA,BS, Nishi Shah, MBBS, MPH, Ioannis Mantzaris, MD MS, Aditi Shastri, MD, Ira Braunschweig, MD, Noah Kornblum, MD, Olga Derman, MD, Amit Verma, MD, Benjamin Zalta, MD, Murali Janakiram, MD MS; Differentiating Lung Involvement in Adult T-Cell Leukemia Lymphoma (ATLL) Versus HTLV Infection: Results from a Large Single-Center Cohort with Implications for Staging and Response Criteria. Blood. 2018; 132Supplement 11630 doi: https://doi.org/10.1182/blood-2018-99-119294.
  13. Nishi Shah, MBBS, MPH, Sakshi Jasra, MD, Ana Acuna-Villaorduna, MD, Urvi A Shah, MD, Gurbakhash Kaur, MD MA,BS, Mohammad Kazemi, Ioannis Mantzaris, MD MS, Aditi Shastri, MD, Olga Derman, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Amit Verma, MD, Murali Janakiram, MD MS; Plasma Cell Dyscrasias in HIV, Epidemiology, Presentation and Treatment Characteristics and Its Strong Association with Hepatitis C- Report Form a Large HIV Cohort. Blood. 2018; 132Supplement 15607 doi: https://doi.org/10.1182/blood-2018-99-119222.
  14. Sakshi Jasra, MD, Mohammad Kazemi, Daniel Cole, Ana Acuna-Villaorduna, MD, Ioannis Mantzaris, MD MS, Aditi Shastri, MD, Olga Derman, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Amit Verma, MD, Murali Janakiram, MD MS; Causes and Predictors of Early Mortality in HIV-Positive and HIV-Negative Patients with Diffuse Large B-Cell Lymphoma. Blood. 2018; 132Supplement 11713 doi: https://doi.org/10.1182/blood-2018-99-120143.
  15. Urvi A Shah, MD, Nishi Shah, MBBS, MPH, Baozhen Qiao, PhD, Ana Acuna Villaorduna, MD, Aditi Shastri, MD, Ioannis Mantzaris, MD MS, Olga Derman, MD, Noah Kornblum, MD, Ira Braunschweig, MD, B. Hilda Ye, PhD, Amit Verma, MD, Murali Janakiram, MD; The Rising Number of Adult T Cell Leukemia Lymphoma (ATLL) Cases in Non-Hispanic Blacks and Its Association with Poor Outcomes. Blood. 2018; 132Supplement 11642 doi: https://doi.org/10.1182/blood-2018-99-111721.
  16. Diego Adrianzen Herrera, MD, Kith Pradhan, PhD, Rosebella Snyder, MD, Siddharth Karanth, MBBS, MPH, DrPH, Murali Janakiram, MD MS, Ioannis Mantzaris, MD MS, Santosh Murthy, MD MPH, Amit Verma, MD, Aditi Shastri, MD; Myelodysplastic Syndromes (MDS) Are an Independent Risk Factor for an Earlier Onset of Myocardial Infarction and Increased Mortality from Cardiovascular Disease (CVD). Blood. 2018; 132Supplement 13539 doi: https://doi.org/10.1182/blood-2018-99-115613.
  17. Ana Acuna Villaorduna, MD, Devika Rao, MD, Yanan Fang, MD PhD, Joshua Heisler, MD, Shirin Attarian, MD, Todd Miller, MD, Louis Juden Reed, MD, Yanhua Wang, MD PhD, Ellen W. Friedman, MD; CT-Guided Biopsies Should Not Replace the Bedside Approach: Clinico-Pathologic Features Associated with Optimal Bone Marrow Procedures. Blood. 2018; 132Supplement 14705 doi: https://doi.org/10.1182/blood-2018-99-117033.
  18. Margarita Kushnir, MD, Yun Choi, MD, Ruth Eisenberg, MS, Devika Rao, MD, Seda Tolu, MD, Jackson Gao, MD, Wenzhu Mowrey, PhD, Henny Heisler Billett, MD; Efficacy and Safety of Direct Oral Factor Xa Inhibitors in 795 Morbidly Obese Patients. Blood. 2018; 132Supplement 1423 doi: https://doi.org/10.1182/blood-2018-99-116396.

2019

  1. Sakshi Jasra, MD, Orsi Giricz, PhD, Rachel Zeig-Owens, M.P.H, David Goldfarb, M.P.H, Angelica Barreto-Galvez, Kith Pradhan, PhD, Jiahao Chen, PhD, Gaurav S Choudhary, PhD, Srinivas Aluri, Tushar D Bhagat, PhD, Aditi Shastri, MD, Victor Thiruthuvanathan, M.S, Hiroki Goto, MD PhD, Jeannine Gerhardt, PhD, Shanisha Gordon, Arul Veerappan, PhD, Syed Hissam Haider, MD, Matthias Bartenstein, MD, George Nwankwo, Ola Landgren, MD PhD, Michael Weiden, MD, Frederick Fletcher, Lee Greenberger, PhD, Benjamin L. Ebert, MD PhD, Ulrich G. Steidl, MD PhD, Britta Will, PhD, Anna Nolan, MD MS, David Prezant, MD, Advaitha Madireddy, PhD, Amit Verma, MBBS; High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster. Blood. 2019; 134Supplement_11551 doi: https://doi.org/10.1182/blood-2019-131107
  2. R. Alejandro Sica, MD, Nishi Shah, MBBS, MPH, Ana Acuna-Villaorduna, MD, Nivetha Vishnuvardan, MD, Urvi A Shah, MD, Diego Adrianzen Herrera, MD, Alyssa De Castro, PharmD, Jennat Mustafa, PA-C, Amanda Lombardo, PA-C, BS, MS, Fariha Khatun, PA-C, Latoya Townsend Nugent, NP, Yanhua Wang, MD PhD, Olga Derman, MD, Noah Kornblum, MD, Ioannis Mantzaris, MD MS, Lizamarie Bachier-Rodriguez, MD, Aditi Shastri, MD, Kira Gritsman, MD PhD, Ulrich G. Steidl, MD PhD, Ira Braunschweig, MD, Amit Verma, MBBS, Murali Janakiram, MD MS, B. Hilda Ye, PhD; Conventional Chemotherapy Treatment Induces Unique Patterns of Clonal Evolution in a North American Adult T Cell Leukemia/Lymphoma Cohort. Blood. 2019; 134Supplement_11551 doi: https://doi.org/10.1182/blood-2019-131107.
  3. Nora E Rahmani, MD, Nandini Ramachandra, Tushar D Bhagat, PhD, Shanisha Gordon, Kith Pradhan, PhD, Bianca Rivera Pena, Mohammad Kazemi, Orsi Giricz, PhD, Shahina Maqbool, Raul Olea, Hamid Dolatshad, Vickram Tittrea, Dharamveer Tatwavedi, Shalini Singh, Andrea Pellagatti, Jacqueline Boultwood, Amit Verma, MBBS; ASXL1 Mutations Are Associated with Widespread and Distinct DNA Methylation Alterations. Blood. 2019; 134Supplement_12989 doi: https://doi.org/10.1182/blood-2019-126850.
  4. Gaurav S Choudhary, PhD, Molly A Smith, PhD, Andrea Pellagatti, Tushar D Bhagat, PhD, Shanisha Gordon, Sanjay Pandey, PhD, Nishi Shah, MBBS, MPH, Srinivas Aluri, Robert N Booher, PhD, Murali Ramachandra, PhD, Maria Elena Samson, Kith Pradhan, PhD, Teresa V. Bowman, PhD, Manoj M Pillai, MD, Chandan Guha, MBBS, Amittha Wickrema, PhD, Britta Will, PhD, Aditi Shastri, MD, Ulrich G. Steidl, MD PhD, Jacqueline Boultwood, Daniel T. Starczynowski, PhD, Amit Verma, MBBS. SF3B1 Mutations Induce Oncogenic IRAK4 Isoforms and Activate Targetable Innate Immune Pathways in MDS and AML. Blood. 2019; 134Supplement_14224 doi: https://doi.org/10.1182/blood-2019-124458.
  5. Srinivas Aluri, Kimo Bachiashvili, MD, Anjali Budhathoki, MD, Tushar D Bhagat, PhD, Gaurav S Choudhary, PhD, Shanisha Gordon, Nandini Ramachandra, Kith Pradhan, PhD, Shahina Maqbool, Aditi Shastri, MD, Jung Im Huh, Sunjin Hwang, Kim Seong-Jin, PhD, Hui Zhang, Britta Will, PhD, Amittha Wickrema, PhD, Ulrich G. Steidl, MD PhD, Amit Verma, MBBS; Clinical ALK5 Inhibitor, Vactosertib, Reverses TGFβ-1 Stimulated Smad-2 Driven Ineffective Hematopoiesis in MDS. Blood. 2019; 134Supplement_12990 doi: https://doi.org/10.1182/blood-2019-127561.
  6. Nishi Shah, MBBS, MPH, Mohammad Kazemi, Stephen Zachary Peeke, MD, Lizamarie Bachier-rodriguez, R.Alejandro Sica, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Aditi Shastri, MD, Amit Verma, MBBS, Ioannis Mantzaris, MD MS; Hispanic and Black Patients with Adult B-Cell Acute Lymphoblastic Leukemia Have a Significantly Worse Survival in the Modern Era - a SEER 2010-2016 Analysis. Blood. 2019; 134Supplement_1426 doi: https://doi.org/10.1182/blood-2019-123168.
  7. B. Hilda Ye, PhD, Elaine Chung, PhD, Kith Pradhan, PhD, Ana Acuna-Villaorduna, MD, Yanhua Wang, MD PhD, Aditi Shastri, MD, Advaitha Madireddy, PhD, Amit Verma, MBBS, R.Alejandro Sica, MD, Murali Janakiram, MD MS; S-Phase Progression of North American ATLL Cells Is Critically Regulated By the Proto-Oncogene BCL6 and Targetable By PARP Inhibition. Blood. 2019; 134Supplement_13779 doi: https://doi.org/10.1182/blood-2019-131364.
  8. Diego Adrianzen Herrera, MD, Kith Pradhan, PhD, Rosebella Snyder, MD, Siddharth Karanth, MBBS, MPH, DrPH, Murali Janakiram, MD MS, Ioannis Mantzaris, MD MS, Santosh Murthy, MD MPH, Amit Verma, MBBS, Aditi Shastri, MD; Risk Stratification and Transfusion Dependence Are Independent Risk Factors for Cardiovascular Disease (CVD) in Myelodysplastic Syndrome (MDS). Blood. 2019; 134Supplement_1336 doi: https://doi.org/10.1182/blood-2019-123317.
  9. Margarita Kushnir, MD, Radhika Gali, MD, Mariam Alexander, MD, Henny Heisler H. Billett, MD; Efficacy and Safety of Direct Oral Factor Xa Inhibitors in Patients after Bariatric Surgery. Blood. 2019; 134Supplement_12439 doi: https://doi.org/10.1182/blood-2019-127645.
  10. Jesus D Gonzalez-Lugo, MD, Ana Acuna-Villaorduna, MD, Urvi A Shah, MD, Ellen W. Friedman, MD; Effect of Active Hepatitis C Infection in Relapse-Free Survival Among Patients with HIV-Related Diffuse Large B-Cell Lymphoma. Blood. 2019; 134Supplement_14132 doi: https://doi.org/10.1182/blood-2019-129379.
  11. Ashley Weiner, Ana Acuna-Villaorduna, Joseph Sparano and Jesus Anampa; Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors. SABCS 2019.
  12. Ana Acuna Villaorduna, Nishi Shah, Sanjay Goel; Clinical features and survival among patients with standard-onset versus early-onset colorectal cancer by age groups. J Clin Oncol 37, 2019 (suppl; abstr 3614).
  13. Nitin Ohri, Haiying Cheng, Shruti Jolly, Shirish M. Gadgeel, Benjamin Thomas Cooper, Elaine Shum, Balazs Halmos; The selective personalized radioimmunotherapy for locally advanced NSCLC trial (SPRINT). J Clin Oncol 37, 2019 (suppl; abstr TPS8571).
  14. Nadia Ashai, Matthew Stuart, Mateo Mejia Saldarriaga, Wei Zhang, Renee Huang, Rahul Narang, Jennifer W. Chuy, Andreas Kaubisch, Sanjay Goel, Balazs Halmos, Lakshmi Rajdev; Cost and effectiveness of genetic testing in metastatic colorectal cancer (mCRC) at Montefiore Medical Center (MMC). J Clin Oncol 37, 2019 (suppl; abstr e15043).
  15. Nadia Ashai, Mateo Mejia Saldarriaga, Devika Rao, Matthew Stuart, Wei Zhang, Sanjay Goel, Balazs Halmos, Lakshmi Rajdev; Molecular analysis of advanced colorectal cancer in a patient cohort of Hispanics, African Americans, and Caucasians within a diverse single institution. J Clin Oncol 37, 2019 (suppl; abstr e15121).
  16. Devika Rao, Ana Acuna Villaorduna, Meghan Kaumaya, Nadia Ashai, Seda Tolu, Adel Chergui, Lakshmi Rajdev, Sanjay Goel; J Clin Oncol 37, 2019 (suppl; abstr e15064).
  17. Nishi Shah, Ana Acuna-Villaorduna, Sanjay Goel; Incidence patterns of early onset colon cancer by race and stage in the US. J Clin Oncol 37, 2019 (suppl; abstr e18168).
  18. Meghan Kaumaya, Wei Zhang, Kevin Kuan, Sorab Gupta, Shaomin Hu, Devika Rao, Kim Ohaegbulam, Richard Hwang, Qiang Liu, Xingxing Zang, Sanjay Goel, Radhashree Maitra; B7-H3 expression by immunohistochemistry as a negative prognostic biomarker in colorectal carcinoma (CRC) in a racially diverse population. J Clin Oncol 37, 2019 (suppl; abstr e15127).
  19. Nishi Shah, Diego Adrianzen Herrera, Urvi Shah, Bhaskar Chandu Kolla, Gurbakhash Kaur, Roberto Alejandro Sica, Aditi Shastri, Ioannis Mantzaris, Amit Verma, Murali Janakiram; Unique racial patterns in rare T-cell lymphomas: A National Cancer Registry analysis from 2001 to 2015. J Clin Oncol 37, 2019 (suppl; abstr e19070).
  20. Ana Acuna Villaorduna, Meghan Kaumaya, Sanjay Goel; Racial disparities in clinico-pathological features and survival rates of early-onset colorectal cancer. J Clin Oncol 37, 2019 (suppl; abstr e15089).
  21. Gurbakhash Kaur, Amanda Podolski, Janki Patel, Jesus Del Santo Anampa Mesias; Body composition change, safety, and efficacy with everolimus use in ethnic minorities with breast cancer. J Clin Oncol 37, 2019 (suppl; abstr e18145).
  22. Diego Andres Adrianzen Herrera, Gaurav Choudhary, Tushar Bhagat, Shanisha Gordon-Mitchell, Hui Zhang, Ulrich Steidl, Britta Will, Gary Eichenbaum, Chandan Guha, Amit Verma; A novel thrombopoietin mimetic RWJ-800088 increases megakaryopoiesis without causing malignant proliferation in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). J Clin Oncol 37, 2019 (suppl; abstr e18527).
  23. Jose Nahun Galeas, Robert M. Grossberg, Maria Serrano, Anna Shmukler, Susan Sakalian, Vikas Mehta, Balazs Halmos, Stuart H. Packer; Improving lung cancer screening in the HIV population. J Clin Oncol 37, 2019 (suppl 27; abstr 69).
  24. Vineeth Sukrithan, Jason Sandler, Rasim A. Gucalp, Richard J. Gralla, Balazs Halmos; Responses to immune checkpoint therapy in pulmonary sarcomatoid carcinoma: A retrospective review. J Clin Oncol 37, 2019 (suppl 8; abstr 115).
  25. Nadia Ashai, Matthew Stuart, Devika Rao, Mateo Mejia Saldarriaga, Wei Zhang, Renee Huang, Rahul Narang, Jennifer W. Chuy, Andreas Kaubisch, Sanjay Goel, Balazs Halmos, Lakshmi Rajdev; Cost and effectiveness of genetic testing in metastatic colorectal cancer (mCRC) at Montefiore Medical Center (MMC). J Clin Oncol 37, 2019 (suppl 4; abstr 643).
  26. Devika Rao, Atrayee Basu Mallick, Amartej Merla, Jeeshan Jiffry, Imran Chaudhary, Titto A Augustine, Lakshmi Rajdev, Andreas Kaubisch, Radhashree Maitra, Sanjay Goel; Excision repair cross-complementing group-1 (ERCC1) gene induction in peripheral blood mononuclear cells as a marker of outcome in patients with colorectal cancer treated with oxaliplatin. J Clin Oncol 37, 2019 (suppl 4; abstr 542).
  27. Ana Acuna Villaorduna, Sanjay Goel; Characteristics and survival among early onset and standard onset colorectal cancer by race. J Clin Oncol 37, 2019 (suppl 4; abstr 522).

2020

  1. Heidi Ko, Yaser Baghdadi, Charito Love, Joseph A. Sparano; Clinical utility of 18F-FDG-PET/CT in staging localized breast cancer prior to initiating preoperative systemic therapy. J Clin Oncol 38: 2020 (suppl; abstr 563).
  2. Michael Wysota, Amanda Jirgal, Ana Acuna-Villaorduna, Shankar Viswanathan, Andreas Kaubisch, Eswar Gadde, Rafi Kabarriti, Sanjay Goel, Jennifer W. Chuy; A phase II trial of preoperative FOLFIRINOX followed by gemcitabine-based chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma (BR PDAC). J Clin Oncol 38: 2020 (suppl; abstr 4638).
  3. Nishi Shah, Riya Jayesh Patel, Astha Thakkar, Shafia Rahman, Ana Acuna-Villaorduna, Urvi Shah, Diego Adrianzen Herrera, Shira Slasky, Kira Gritsman, Mendel Goldfinger, Noah Saul Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier-Rodriguez, Ira Braunschweig, Amit Verma, Katharine Anne McNeill, B. Hilda Ye, Murali Janakiram, R. Alejandro Sica; CNS involvement by North American-ATLL (NA-ATLL) is associated with discrete patterns and molecular profile involving XPO1 E571 and KLF2/PI3KCD in selected cases. J Clin Oncol 38: 2020 (suppl; abstr 8063).
  4. Zunaira H Choudhary, Shailesh M Advani, Nadia Ashai, Sara Tariq, Axel Grothey, Scott Kopetz, Lakshmi Rajdev; A multi-institution analysis of molecular biomarkers in patients with metastatic colorectal cancer in ethnically diverse populations. J Clin Oncol 38: 2020 (suppl; abstr e16074).
  5. Adel Chergui, Eswar Gadde, Ana Acuna-Villaorduna, Rafi Kabarriti, Sanjay Goel, Andreas Kaubisch; Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with immunotherapy: A “real world” retrospective study. J Clin Oncol 38: 2020 (suppl; abstr e16644).
  6. Seda Serra Tolu, Adel Chergui, Devika Rao, Meghan Kaumaya, Ana Acuna-Villaorduna, Andreas Kaubisch, Jennifer W. Chuy, Lakshmi Rajdev, Tarek N. Elrafei, Sanjay Goel; The impact of biologic agents in patients with metastatic colorectal cancer by race/ethnicity. J Clin Oncol 38, 2020 (suppl 4; abstr 156).
  7. Adel Chergui, Eswar Gadde, Seda Serra Tolu, Ana Acuna-Villaorduna, Rafi Kabarriti, Sanjay Goel, Andreas Kaubisch; Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with immunotherapy: A real-world retrospective study. J Clin Oncol 38, 2020 (suppl 4; abstr 557).
  8. Robert Lopez, Anna C. Ferrari, Sanjay Goel, Stephen Peeke, Janaki Neela Sharma, Niraj Konchady Shenoy, Benjamin Adam Gartrell; Genomic profiling of prostate cancer at a diverse academic center. J Clin Oncol 38, 2020 (suppl 6; abstr 64).

Articles

2018

  1. Shah UA, Chung EY, Giricz O, Pradhan K, Kataoka K, Gordon-Mitchell S, Bhagat TD, Mai Y, Wei Y, Ishida E, Choudhary GS, Joseph A, Rice R, Gitego N, Parrish C, Bartenstein M, Goel S, Mantzaris I, Shastri A, Derman O, Binder A, Gritsman K, Kornblum N, Braunschweig I, Bhagat C, Hall J, Graber A, Ratner L, Wang Y, Ogawa S, Verma A, Ye BH, Janakiram M. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood. 2018;132(14):1507-1518. doi:10.1182/blood-2018-01-824607.
  2. Adrianzen Herrera DA, Goldberg-Stein S, Sankin A, Sarungbam J, Sharma J, Gartrell BA. Synchronous Bone Metastasis From Multiple Myeloma and Prostate Adenocarcinoma as Initial Presentation of Coexistent Malignancies. Front Oncol. 2018;8:137. Published 2018 Apr 30. doi:10.3389/fonc.2018.00137.
  3. Attarian S, Reed L, Singh S, Shestopalov A, Singh AP, Budhathoki A, Abi-Aad S, Shah UA, Kim S, Bachiashvili K, Elrafei T, Li W, Yee C, Friedman EW.Visualization of the bone marrow biopsy needle track. Am J Hematol. 2018;93(3):E60-E61. doi:10.1002/ajh.24985
  4. Ko B, Halmos B. Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?. Transl Lung Cancer Res. 2018;7(Suppl 4):S321-S325. doi:10.21037/tlcr.2018.12.05.
  5. Janakiram M, Jasra S, Aboulafia D. Effect of Hepatitis B and C Infection on Recruitment for Cancer Clinical Trials. J Clin Oncol. 2018;36(10):1047-1048. doi:10.1200/JCO.2017.76.9307.
  6. Singh AP, Adrianzen Herrera D, Zhang Y, Perez-Soler R, Cheng H; Mouse Models in Squamous Cell Lung Cancer: Impact for Drug Discovery. Expert Opin Drug Discov. 2018 Apr;13(4):347-358. doi: 10.1080/17460441.2018.1437137. Epub 2018 Feb 15. PMID: 29394493.
  7. Cheng H, Borczuk A, Janakiram M, Ren X, Lin J, Assal A, Halmos B, Perez-Soler R, Zang X. Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers. Clin Cancer Res. 2018 Apr 15;24(8):1954-1964. doi: 10.1158/1078-0432.CCR-17-2924. Epub 2018 Jan 26. PMID: 29374053.
  8. Jasra S, Anampa J; Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review. Curr Treat Options Oncol. 2018 May 11;19(6):30. doi: 10.1007/s11864-018-0547-8.PMID: 29752560.
  9. Kim S, Barzi A, Rajdev L; Biomarker-driven Targeted Therapies for gastric/gastro-esophageal Junction Malignancies. Semin Oncol. 2018 Jun;45(3):133-150. doi: 10.1053/j.seminoncol.2018.03.001. Epub 2018 Mar 20. PMID: 30262395
  10. Janakiram M, Verma A, Wang Y, Budhathoki A, Suarez Londono J, Murakhovskaya I, Braunschweig I, Minniti CP.. Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease. Leuk Lymphoma. 2018;59(1):241-244. doi:10.1080/10428194.2017.1324158.
  11. Shah UA, Viswanathan S, Agarwal B, Shastri A, Mantzaris I, Janakiram M, Kornblum N, Braunschweig I, Verma A, Shi Y, Reinus J, Derman O. Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure. Case Rep Oncol Med. 2018; 2018:5382852. Published 2018 Dec 3. doi:10.1155/2018/5382852.
  12. Licata MJ, Janakiram M, Tan S, Fang Y, Shah UA, Verma AK, Wang Y. Diagnostic challenges of adult T-cell leukemia/lymphoma in North America - a clinical, histological, and immunophenotypic correlation with a workflow proposal. Leuk Lymphoma. 2018;59(5):1188-1194.
  13. Reed LJ, Attarian S, Olson TR, Singh S, Shestopalov A, Friedman EW. Feasibility and safety of targeting the anterior superior iliac spine to perform a bone marrow procedure: a prospective, clinical study. J Clin Pathol. 2018;71(12):1116-1119.
  14. Alexander M, Halmos B. VEGF inhibitors in EGFR-mutated lung cancer: a never-ending story? Ann Transl Med. 2018;6(23):446. doi:10.21037/atm.2018.11.20.

2019

  1. Adrianzen Herrera D, Kornblum N, Derman O, Bachier-Rodriguez L, Sica RA, Shastri A, Janakiram M, Verma A, Braunschweig I, Mantzaris I.Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts. Clin Lymphoma Myeloma Leuk. 2019;19(8):516-521. doi:10.1016/j.clml.2019.05.002.
  2. Acuna-Villaorduna A, Tran V, Gonzalez-Lugo JD, Azimi-Nekoo E, Billett HH. Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: A retrospective cohort study. Thromb Res. 2019;174:137-140. doi:10.1016/j.thromres.2018.12.019.
  3. Sridharan A, Schinke CD, Georgiev G, Da Silva Ferreira M, Thiruthuvanathan V, MacArthur I, Bhagat TD, Choudhary GS, Aluri S, Chen J, Pradhan K, Xia Y, Panjikaran M, Sims G, Bhagat CK, Bender R, Keeler L, Graber A, Heuck C, Fletcher FA, Alapat D, Weinhold N, Johnson SK, Wickrema A, Barlogie B, Morgan GJ, Shastri A, Steidl U, Will B, Verma A. Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias. Blood Adv. 2019;3(23):3962-3967. doi:10.1182/bloodadvances.2019000731.
  4. Hemmati S, Sinclair T, Tong M, Bartholdy B, Okabe RO, Ames K, Ostrodka L, Haque T, Kaur I, Mills TS, Agarwal A, Pietras EM, Zhao JJ, Roberts TM, Gritsman K. PI3 kinase alpha and delta promote hematopoietic stem cell activation. JCI Insight. 2019;5(13):e125832. Published 2019 May 23. doi:10.1172/jci.insight.1258.
  5. Adrianzen Herrera D, Kornblum N, Acuna-Villaorduna A, Sica RA, Shah U, Butler M, Vishnuvardhan N, Shah N, Bachier-Rodriguez L, Derman O, Shastri A, Mantzaris I, Verma AK, Braunschweig I, Janakiram M. Characteristics and outcomes of progressive multifocal leukoencephalopathy in hematologic malignancies and stem cell transplant - a case series. Leuk Lymphoma. 2019;60(2):395-401. doi:10.1080/10428194.2018.1474523.
  6. Sukrithan V, Sandler J, Gucalp R, Gralla R, Halmos B. Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma. Clin Lung Cancer. 2019;20(3):e242-e246. doi:10.1016/j.cllc.2018.12.013.
  7. Adrianzen Herrera D, Ashai N, Perez-Soler R, Cheng H.Nanoparticle Albumin Bound-Paclitaxel for Treatment of Advanced Non-Small Cell Lung Cancer: An Evaluation of the Clinical Evidence. Expert Opin Pharmacother. 2019 Jan;20(1):95-102. doi: 10.1080/14656566.2018.1546290. Epub 2018 Nov 15. PMID: 30439289.
  8. Augustine T, Maitra R, Zhang J, Nayak J, Goel S; Sensitization of Colorectal Cancer to Irinotecan Therapy by PARP Inhibitor Rucaparib. Invest New Drugs. 2019 Oct;37(5):948-960. doi: 10.1007/s10637-018-00717-9. Epub 2019 Jan 5. PMID: 30612311.
  9. Peeke SZ, Gritsman K. Twist of Fate for Acute Promyelocytic Leukemia: TRIB3-TWIST1 Interaction Promotes Resistance. Clin Cancer Res. 2019 Oct 15; 25(20):6018-6020. doi: 10.1158/1078-0432.CCR-19-2140. Epub 2019 Aug 12. PMID: 31405833.
  10. Galeas JN, Gaspe N, Pradhan K, Cordero H, Verma A, Goel S. Anisocytosis Is a Poor Prognostic Factor in Secondary Polycythemia. Leuk Lymphoma. 2019 Dec; 60(13):3287-3291. doi: 10.1080/10428194.2019.1622701. Epub 2019 Jun 13. PMID: 31190587.
  11. Wang H, Kaur G, Sankin AI, Chen F, Guan F, Zang X.Immune Checkpoint Blockade and CAR-T Cell Therapy in Hematologic Malignancies. J Hematol Oncol. 2019 Jun 11;12(1):59. doi: 10.1186/s13045-019-0746-1. PMID: 31186046.
  12. Acuna-Villaorduna A, Gonzalez-Lugo J, Ye BH, Adrianzen Herrera DA, Sica RA, Shah U, Shah N, Kornblum N, Braunschweig I, Derman O, Mantzaris I, Shastri A, Wang Y, Verma A, Zalta B, Janakiram M. High Prevalence of Pulmonary Findings in Computed Tomographies of HTLV-1-infected Patients With and Without adult-T Cell leukemia/lymphoma - Implications for Staging. Leuk Lymphoma. 2019 Dec;60(13):3272-3276. doi: 10.1080/10428194.2019.1627543. Epub 2019 Jun 17. PMID: 31204876.
  13. Kam AE, Pendurti G, Shah UH, Ghalib MH, Chaudhary I, Chuy J, Rajdev L, Kaubisch A, Aparo S, Mantzaris I, Goel S; Survival Outcome and Prognostic Model of Patients With Colorectal Cancer on Phase 1 Trials. Invest New Drugs. 2019 Jun;37(3):490-497. doi: 10.1007/s10637-018-0675-9. Epub 2018 Oct 12. PMID: 30315379.
  14. Sukrithan V, Deng L, Barbaro A, Cheng H; Emerging Drugs for EGFR-mutated Non-Small Cell Lung Cancer. Expert Opin Emerg Drugs. 2019 Mar;24(1):5-16. doi: 10.1080/14728214.2018.1558203. Epub 2018 Dec 20. PMID: 30570396.
  15. Kushnir M, Choi Y, Eisenberg R, Rao D, Tolu S, Gao J, Mowrey W, Billett HH. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. Lancet Haematol. 2019 Jul;6(7):e359-e365. doi: 10.1016/S2352-3026(19)30086-9. Epub 2019 May 24. PMID: 31133411.
  16. Rao D, Mallick AB, Augustine T, Daroqui C, Jiffry J, Merla A, Chaudhary I, Seetharam R, Sood A, Gajavelli S, Aparo S, Rajdev L, Kaubisch A, Chuy J, Negassa A, Mariadason JM, Maitra R, Goel S. Excision Repair Cross-Complementing group-1 (ERCC1) Induction Kinetics and Polymorphism Are Markers of Inferior Outcome in Patients With Colorectal Cancer Treated With Oxaliplatin. Oncotarget. 2019 Sep 17;10(53):5510-5522. doi: 10.18632/oncotarget.27140. eCollection 2019 Sep 17. PMID: 31565185.
  17. Galeas JN, Gaspe N, Pradhan K, Cordero H, Verma A, Goel S. Anisocytosis is a poor prognostic factor in secondary polycythemia. Leuk Lymphoma. 2019;60(13):3287-3291. doi:10.1080/10428194.2019.1622701.
  18. Adrianzen Herrera D, Ashai N, Perez-Soler R, Cheng H. Nanoparticle Albumin Bound-Paclitaxel for Treatment of Advanced Non-Small Cell Lung Cancer: An Evaluation of the Clinical Evidence. Expert Opin Pharmacother. 2019 Jan;20(1):95-102. doi: 10.1080/14656566.2018.1546290. Epub 2018 Nov 15. PMID: 30439289.
  19. Kushnir M, Choi Y, Eisenberg R, Rao D, Tolu S, Gao J, Mowrey W, Billett HH. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. Lancet Haematol. 2019;6(7):e359-e365. doi:10.1016/S2352-3026(19)30086-9
  20. Augustine T, Maitra R, Zhang J, Nayak J, Goel S; Sensitization of Colorectal Cancer to Irinotecan Therapy by PARP Inhibitor Rucaparib. Invest New Drugs. 2019 Oct;37(5):948-960. doi: 10.1007/s10637-018-00717-9. Epub 2019 Jan 5. PMID: 30612311.

2020

  1. Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Braunschweig I, Budhathoki A, Shah UA, Verma AK, Murthy SB, Shastri A. Myelodysplastic Syndromes and the Risk of Cardiovascular Disease in Older Adults: A SEER-medicare Analysis. Leukemia. 2020 Jun;34(6):1689-1693. doi: 10.1038/s41375-019-0673-8. Epub 2019 Dec 16. PMID: 31844145.
  2. Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Braunschweig I, Budhathoki A, Shah UA, Verma AK, Murthy SB, Shastri A. Myelodysplastic Syndromes and the Risk of Cardiovascular Disease in Older Adults: A SEER-medicare Analysis. Leukemia. 2020 Jun;34(6):1689-1693. doi: 10.1038/s41375-019-0673-8. Epub 2019 Dec 16. PMID: 31844145.
  3. Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, Pradhan K, Thota R, Reissman S, Sparano JA, Gartrell BA, Smith RV, Ohri N, Garg M, Racine AD, Kalnicki S, Perez-Soler R, Halmos B, Verma A. Case Fatality Rate of Cancer Patients With COVID-19 in a New York Hospital System. Cancer Discov. 2020 May 1. doi: 10.1158/2159-8290.CD-20-0516.
  4. Verma A, Suragani RN, Aluri S, Shah N, Bhagat TD, Alexander MJ, Komrokji R, Kumar R. Biological Basis for Efficacy of Activin Receptor Ligand Traps in Myelodysplastic Syndromes. J Clin Invest. 2020 Feb 3;130(2):582-589. doi: 10.1172/JCI133678. PMID: 31961337.
  5. Deng Q, Fang Q, Sun H, Singh AP, Alexander M, Li S, Cheng H, Zhou S. Detection of Plasma EGFR Mutations for Personalized Treatment of Lung Cancer Patients Without Pathologic Diagnosis. Cancer Med. 2020 Mar;9(6):2085-2095. doi: 10.1002/cam4.2869. Epub 2020 Jan 28. PMID: 31991049.
  6. Sukrithan V, Barbaro A, Chergui A, Ko B, Lin J, Cheng H, Goel S. Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non-Small Cell Lung Cancer. Am J Clin Oncol. 2020 Jan;43(1):64-68. doi: 10.1097/COC.0000000000000628. PMID: 31764022.
  7. Alexander M, Ko B, Lambert R, Gadgeel S, Halmos B. The Evolving Use of Pembrolizumab in Combination Treatment Approaches for Non-Small Cell Lung Cancer. Expert Rev Respir Med. 2020 Feb;14(2):137-147. doi: 10.1080/17476348.2020.1702526. Epub 2019 Dec 17. PMID: 31815565.
  8. Singh AP, Shum E, Rajdev L, Cheng H, Goel S, Perez-Soler R, Halmos B. Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice. Cancers (Basel). 2020 May 4;12(5):1156. doi: 10.3390/cancers12051156. PMID: 32375398.
  9. Sukrithan V, Barbaro A, Chergui A, Ko B, Lin J, Cheng H, Goel S. Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non-Small Cell Lung Cancer. Am J Clin Oncol. 2020;43(1):64-68. doi:10.1097/COC.0000000000000628.
  10. Gonzalez-Lugo JD, Bachier-Rodriguez L, Goldfinger M, Shastri A, Sica RA, Gritsman K, Mehta V, Kabarriti R, Goel S, Verma A, Braunschweig I, Kornblum N, Mantzaris I. A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19 [published online ahead of print, 2020 Jun 1]. Br J Haematol. 2020;10.1111/bjh.16906. doi:10.1111/bjh.16906.
  11. Abbasi A, Peeke S, Shah N, Mustafa J, Khatun F, Lombardo A, Abreu M, Elkind R, Fehn K, de Castro A, Wang Y, Derman O, Nelson R, Uehlinger J, Gritsman K, Sica RA, Kornblum N, Mantzaris I, Shastri A, Janakiram M, Goldfinger M, Verma A, Braunschweig I, Bachier-Rodriguez L. Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis. J Hematol Oncol. 2020;13(1):1. Published 2020 Jan 3. doi:10.1186/s13045-019-0838-y.
  12. Xiao Z, Acuna-Villaorduna A, Mantzaris I. Brachial plexopathy following autologous hematopoietic stem cell transplant: an unrecognized complication of autologous transplantation. Leuk Lymphoma. 2020;61(1):243-245. doi:10.1080/10428194.2019.1654094.
  13. Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Braunschweig I, Budhathoki A, Shah UA, Verma AK, Murthy SB, Shastri A. Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis. Leukemia. 2020;34(6):1689-1693. doi:10.1038/s41375-019-0673-8.
  14. Alexander M, Ko B, Lambert R, Gadgeel S, Halmos B. The evolving use of pembrolizumab in combination treatment approaches for non-small cell lung cancer. Expert Rev Respir Med. 2020;14(2):137-147. doi:10.1080/17476348.2020.1702526.
  15. Deng Q, Fang Q, Sun H, Singh AP, Alexander M, Li S, Cheng H, Zhou S. Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis. Cancer Med. 2020;9(6):2085-2095. doi:10.1002/cam4.2869.

Take the Hematology-Oncology Fellowship Program Virtual Tour

See why so many applicants choose Montefiore-Einstein